492 related articles for article (PubMed ID: 34680337)
1. Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies.
Bauer M; Jasinski-Bergner S; Mandelboim O; Wickenhauser C; Seliger B
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680337
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.
Zheng X; Huang Y; Li K; Luo R; Cai M; Yun J
Viruses; 2022 May; 14(5):. PubMed ID: 35632758
[TBL] [Abstract][Full Text] [Related]
3. The Microenvironment in Epstein-Barr Virus-Associated Malignancies.
Tan GW; Visser L; Tan LP; van den Berg A; Diepstra A
Pathogens; 2018 Apr; 7(2):. PubMed ID: 29652813
[TBL] [Abstract][Full Text] [Related]
4. Immune Evasion by Epstein-Barr Virus.
Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas.
Dolcetti R
Semin Cancer Biol; 2015 Oct; 34():58-69. PubMed ID: 25953434
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies.
Leong MML; Lung ML
Front Oncol; 2021; 11():629780. PubMed ID: 33718209
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.
Wang M; Yu F; Wu W; Wang Y; Ding H; Qian L
Int J Biol Sci; 2018; 14(5):565-576. PubMed ID: 29805308
[TBL] [Abstract][Full Text] [Related]
11. An update: Epstein-Barr virus and immune evasion via microRNA regulation.
Zuo L; Yue W; Du S; Xin S; Zhang J; Liu L; Li G; Lu J
Virol Sin; 2017 Jun; 32(3):175-187. PubMed ID: 28669004
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.
Grossman L; Chang C; Dai J; Nikitin PA; Jima DD; Dave SS; Luftig MA
mSphere; 2017; 2(6):. PubMed ID: 29202043
[TBL] [Abstract][Full Text] [Related]
14. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
Long X; Li Y; Yang M; Huang L; Gong W; Kuang E
J Virol; 2016 Sep; 90(17):7880-93. PubMed ID: 27334596
[TBL] [Abstract][Full Text] [Related]
15. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
16. The role of Epstein-Barr virus in epithelial malignancies.
Tsao SW; Tsang CM; To KF; Lo KW
J Pathol; 2015 Jan; 235(2):323-33. PubMed ID: 25251730
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
Paludan C; Münz C
Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
[TBL] [Abstract][Full Text] [Related]
18. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
19. EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies.
Williams MV; Mena-Palomo I; Cox B; Ariza ME
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765813
[TBL] [Abstract][Full Text] [Related]
20. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
